XReality Group

Los Angeles Police Special Weapons and Tactics (SWAT) Sign for Trial of Operator XR Technology

xReality Group Limited (ASX:XRG) is pleased to announce, Following extensive demonstrations during Q1 FY24, the Department requested a formal trial of the technology, over a 3 month period expected to commence in February 2024. The trial will integrate Operator XR technology into the current SWAT training program, gather more sustained exposure to team members and commanders, for the purposes of assessing a fit into the SWAT training programs.


  • Operator XR has been accepted by Los Angeles Police Department (LAPD) SWAT for a trial of its Virtual Reality Tactical Training solution.
  • Commencing in February, the trial will run for 3 months, and be used by the 67 SWAT members and team commanders of the LAPD SWAT Team, Metro Division.
  • LAPD SWAT is known as one of the foremost police tactical units in the world, earning hundreds of commendations and citations, including several Medals of Valor, the Department’s highest award for heroism in the line of duty.
  • Operator XR technology will be assessed and reviewed as a training system to supplement and enhance current SWAT training, in support of the teams roles and responsibilities towards upholding public safety.

Operator XR will allow LAPD SWAT to train operational tactics and procedures using a system which is a highly portable, easy to use and realistic Virtual Reality system that does not require internet, is highly secure and easily to use.

Virtual Reality based training with Operator XR technology offers a low cost, and low risk approach to traditional training approaches, reduces demand on staffing resources and at the same time increases officer exposure and throughput to high intensity, high stress virtual situations that increases and enhances situational awareness, leading to improved outcomes in high risk law enforcement situations.

This system will enable LAPD SWAT to plan and train active shooter scenarios, hostage rescues, and crisis interventions which can be difficult to train using traditional methods.

Operator XR software has been developed by xReality Group, using the latest innovations in Virtual Reality technology, coupled with the considerable expertise of XRG management in former career duties in front line Military and Policing.

XRG will not charge LAPD SWAT to use the Operator XR technology during the 3 month trial period, but are confident that the success of the trial will lead to revenue earning opportunities from this and other follow up arrangements with other US State and Federal law enforcement agencies.

Martin Beck, LAPD SWAT, said“We are looking forward to extensive testing of Operator XR with our team over the coming 3 months, this trial will help us understand how technology can complement our current training programs, and enhance the public safety outcomes.”

Wayne Jones, CEO, XRG, said “Building on the momentum of Operator XR in the USA, a trial with the Los Angeles SWAT for our VR training systems is a huge step for XRG. Trialling Operator XR, the highly advanced VR tactical rehearsal system, with one of the worlds most respected tactical policing agencies, is expected to open significant opportunities. It's a major test of our technology in a critical environment, and we're ready to show its impact on tactical training and operational readiness."


Click here for the full ASX Release

This article includes content from XReality Group, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

XRG:AU
XReality Group

XReality Group Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
XReality Group (ASX:XRG)

XReality Group


Keep reading...Show less
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less
XReality Group

XReality Group Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News

×